Journal
CELL METABOLISM
Volume 15, Issue 2, Pages 150-156Publisher
CELL PRESS
DOI: 10.1016/j.cmet.2012.01.002
Keywords
-
Categories
Funding
- National Institute of Diabetes and Digestive and Kidney Diseases
Ask authors/readers for more resources
The widespread use of the inadequately defined term leptin resistance led the National Institutes of Health to convene a workshop aimed at developing a quantitative definition of this term that would facilitate mechanistic research into leptin's actions in human health and disease. Although leptin-responsive conditions are recognized, the field is limited by a lack of robust, easily quantifiable behavioral or metabolic biomarkers of the hormone's action. Further advances require biomarkers that can be used to identify patients who may benefit from leptin therapy and that are useful for understanding the determinants of clinical leptin responsiveness.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available